AORT Artivion Earnings and EPS analysis

Relative Growth: Rel. Growth: 82

Relative Strength: Rel. Strength: 4

Relative Valuation: Rel. Valuation: 54

Relative Profitability: Rel. Profitability: 69

EPS in 2026 (TTM): $0.26

Last Report Period Date: Mar 31, 2026

According to the most recent financial data from March 2026, the current EPS (TTM) is $0.26. Artivion's EPS for 2025 came in at $0.22, marking an increase from -$0.32 in 2024. For the quarterly period ending on Mar 31, 2026, AORT's EPS was $0.03.

AORT earnings history

Historical annual and quarterly earnings per share (EPS) data for Artivion

EPS (TTM)

$0.26

EPS Growth YoY (Quarterly)

400%

EPS (Quarterly)

$0.03

EPS Growth (Quarterly)

-50%

Artivion had an annual EPS of $0.22, marking an increase of 168.8% from -$0.32 in 2024. The quarterly EPS for the period ending Mar 31, 2026, was $0.03, marking a 400% increase from the same quarter last year. AORT's TTM EPS stands at $0.26 as of March 2026. Artivion's EPS for 2024 stood at -$0.32, a 57.3% increase from 2023.

AORT earnings chart

AORT EPS growth history

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

400%

EPS growth YoY

168.8%

EPS growth 3Y avg

N/A

EPS growth 5Y avg

N/A

Over the last 12 months, Artivion has registered an EPS growth of 400% (YoY, quarterly). A 10-year view shows that AORT has seen an average EPS growth of 4.6% per year.

AORT Earnings Waterfall

Breakdown of revenue, profit and net income for Artivion

AORT Earnings vs Peers

What are the earnings of AORT compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
BSX Boston Scientific Corp	20.24	55.6%	63.3%	N/A
ZBH Zimmer Biomet Holdings Inc	22.34	-20%	47.9%	N/A
MDT Medtronic plc	22.75	31%	-1.1%	0.3%
ABT Abbott Laboratories	25.08	-51.4%	-1.8%	8.2%
PODD Insulet Corp	34.14	-41.2%	268.8%	99.9%
SYK Stryker Corp	34.34	8%	10.9%	14.8%
EW Edwards Lifesciences Corp	46.16	-73.6%	-9.2%	6.9%
AORT Artivion Inc	80.27	168.8%	N/A	N/A
TFX Teleflex Inc	N/A	-1,462.4%	N/A	N/A
IART Integra Lifesciences Holdings Corp	N/A	-7,388.9%	N/A	N/A

All data is based on quarterly TTM periods, unless otherwise specified.